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Cationic polymers for DNA origami coating –
examining their binding efficiency and tuning
the enzymatic reaction rates†
Jenny K. Kiviaho,‡a Veikko Linko,‡a Ari Ora,a Tony Tiainen,b Erika Järvihaavisto,a
Joona Mikkilä,a Heikki Tenhu,b Nonappac and Mauri A. Kostiainen*a
DNA origamis are fully tailored, programmable, biocompatible and readily functionalizable nanostructures
that provide an excellent foundation for the development of sophisticated drug-delivery systems.
However, the DNA origami objects suffer from certain drawbacks such as low cell-transfection rates and
low stability. A great deal of studies on polymer-based transfection agents, mainly focusing on polyplex
formation and toxicity, exists. In this study, the electrostatic binding between a brick-like DNA origami and
cationic block-copolymers was explored. The effect of the polymer structure on the binding was investi-
gated and the toxicity of the polymer–origami complexes evaluated. The study shows that all of the ana-
lyzed polymers had a suitable binding efficiency irrespective of the block structure. It was also observed
that the toxicity of polymer–origami complexes was insignificant at the biologically relevant concen-
tration levels. Besides brick-like DNA origamis, tubular origami carriers equipped with enzymes were also
coated with the polymers. By adjusting the amount of cationic polymers that cover the DNA structures,
we showed that it is possible to control the enzyme kinetics of the complexes. This work gives a starting
point for further development of biocompatible and effective polycation-based block copolymers that
can be used in coating different DNA origami nanostructures for various bioapplications.
Introduction
Structural DNA nanotechnology has made considerable pro-
gress especially during the past decade.1 New techniques to
design and construct precise DNA nano-objects have emerged
since the pioneering work of Nadrian Seeman.2,3 Currently,
the most versatile and common method to produce DNA nano-
objects is the DNA origami technique, which is based on the
thermal annealing of long single-stranded DNA with comp-
lementary short oligonucleotides to form stable and well-
defined two and three-dimensional nano-objects.4–7
As the DNA origami technique enables precise design and
production8 of nanometer-scale shapes, it is employed in
various applications such as protein and DNA analysis,9–11
microscopy,12 plasmonics,13 molecular engineering14,15
and nanoscale patterning.16–18 Furthermore, DNA origami is
an extremely promising platform for creating sophisticated
drug-delivery vehicles and molecular devices for bio-
nanotechnology.19–21 DNA origamis, and DNA nano-objects in
general, are found to be biocompatible, non-toxic and only
mildly immunogenic, and moreover, they are able to enter
cells with and without the help of transfection agents.21–27 The
origamis are reported to tolerate various cell lysates and
nucleases, which suggests that they could remain intact under
physiological conditions to some extent.8,28 Additionally, DNA
origamis exhibit enhanced permeability and retention (EPR)
effect, which results in passive tumor-targeting and an
accumulation of nano-objects into the tumor region.24 This
makes DNA origami an attractive candidate for anti-cancer
applications. It has also been suggested that DNA origami
drug carriers could serve as a means to circumvent the drug
resistance of certain cancer types.23
Although cells internalize bare DNA origamis, the cell
uptake is significantly increased when transfection agents are
applied. The uptake of origamis is improved considerably
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when e.g. the commercial lipid-based transfection agent, Lipo-
fectamine®, is employed.29 Similarly, by coating the origami
with virus capsid proteins, the cell uptake can be enhanced.30
In addition, the pharmacokinetic bioavailability can be
increased by encapsulating origamis with lipid membranes.31
This implies that DNA origamis require an auxiliary substance
in order to efficiently enter the cells, and moreover, coating/
encapsulation could be the key factor in enhancing their stabi-
lity in biologically relevant environments. Numerous studies
on traditional non-viral carriers, including cationic polymers
and dendrimers, show that synthetic organic carriers can
prolong the in vivo half-life and enhance the cell transfection
of drugs or genetic material.32,33 Thus, it is justified to hypoth-
esize that these materials could also improve the cell transfec-
tion of DNA origami nano-objects.
Cationic polymers are a particularly interesting class of
transfection agents, since they can be readily synthesized and
a variety of functionalities can be incorporated into the
polymer chains. Even stimuli-responsive behavior is achievable
through copolymer structures.34–36 Cationic polymers are
associated with relatively low immunogenicity and reasonable
transfection efficiency, but unfortunately they exhibit some
cytotoxicity. For example poly(l-lysine) (PLL), poly(2-dimethyl-
aminoethyl methacrylate) (PDMAEMA) and branched and
linear polyethylenimine (PEI) are widely studied polycations.
Additionally, PLL demonstrates low transfection efficiency and
no buffering capacity.37,38 PEI, in contrast, is an effective trans-
fection agent, but associated with high cytotoxicity and haemo-
lytic activity.39–41 PDMAEMA and PDMAEMA-based polyplexes,
on the other hand are found less toxic than PEI and the corres-
ponding polyplexes, while the transfection efficiency is com-
parable to that of branched PEI.42,43 In addition, PDMAEMA-
based polymers do not induce red blood cell aggregation nor
demonstrate haemolytic activity in whole blood.41
Despite the lower toxicity and non-haemolytic nature,
PDMAEMA still faces certain limitations regarding biocompat-
ibility. Furthermore, bare PDMAEMA–DNA complexes may
possess poor colloidal stability. These limitations could be
overcome by incorporating additional blocks to the polymer
structure. Suitable blocks could decrease the toxicity of the
system and even increase the colloidal stability and blood cir-
culation times.38 A good candidate for reducing the cyto-
toxicity is a hydrophilic polymer widely employed in
biomedical applications, poly(ethylene glycol) (PEG). PEG is a
good example of a polymer that provides protection for nano-
particles and proteins against the reticulo-endothelial system,
thus prolonging the circulation time. It also prevents aggrega-
tion and improves particle stability.44
In this work, 2-(dimethylamino)ethyl methacrylate was poly-
merized employing poly(ethylene glycol)-based macroinitiators
to explore the electrostatic binding between a brick-like DNA
origami and the block copolymers (Fig. 1).
The PEG-moiety was incorporated into the polymers to
expectedly improve the biocompatibility of PDMAEMA and to
provide additional protection and colloidal stability to the pro-
posed DNA origami–polymer particles. Two different block
copolymer structures, AB-type diblock and ABA-type triblock
structures, and PDMAEMA homopolymer (HP) were studied.
The aim of the work is to understand the effect of polymer
structure on the binding and to investigate if the utilization of
the polymers in biomedical applications is feasible. Further-
more, to test the conceivable applications of the polymer–DNA
complexes, tubular DNA origamis were loaded with enzymes
and coated with varying amounts of polymers in order to
control the enzymatic reaction rates.
Results and discussion
Polymer properties
To study the electrostatic binding of cationic PDMAEMA-
based polymers on the anionic DNA origami surface, a
set of polymers were synthesized. Polymers with different
structures were prepared, including PDMAEMA homopolymer
(HP), PDMAEMA-PEG (AB-type) diblock copolymer and
PDMAEMA-PEG-PDMAEMA (ABA-type) triblock copolymer
(Fig. 2).
All the polymers were synthesized by employing the Atom
Transfer Radical Polymerization (ATRP) technique. ATRP
enables fast reactions under mild conditions and allows pro-
duction of polymers with narrow molecular weight distri-
butions and set molecular weights. Low polydispersity indices
(PDIs) and the ability to produce polymers with desired mole-
cular weights is especially important in biomedical appli-
cations where it is crucial to generate well-defined polymer
bioconjugates.45–47 PEG was introduced to the polymers by
using PEG monomethyl ether (mPEG, 5000 g mol−1) and
difunctional PEG (4000 g mol−1) macroinitiators in DMAEMA
polymerization.
Both the macroinitiator and polymer syntheses were suc-
cessful. The structural integrity of macroinitiators was con-
firmed with 1H NMR and IR spectroscopy, size exclusion
chromatography (SEC) and matrix-assisted laser desorption/
ionization time-of-flight (MALDI-ToF) mass spectrometry (spe-
cifications on characterization can be found in the ESI†). 1H
NMR and IR confirmed the presence of the initiator groups on
mPEG and PEG chains after esterification. SEC affirmed that
esterification reaction did not result in uncontrolled chain
breaking or other side reactions as the polydispersity index
Fig. 1 Scaffold strand folds into desired shape with the help of staple
strands. Each cylinder on the origami represents a DNA double helix.
DNA origami possesses a negative surface charge, which enables the
electrostatic binding of the cationic polymers.
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(PDI) of both PEGs remained narrow. Also the masses
obtained from MALDI-ToF spectroscopy corresponded to the
theoretical mass values of the macroinitiators.
1H NMR, IR, MALDI-ToF and SEC data also confirmed the
successful block copolymer syntheses. Polymers with desired
molecular weights and relatively low PDIs were obtained
(Table 1). The total molecular weights of the polymers vary,
but the size of the PDMAEMA block in polymers is roughly the
same, ∼6000 g mol−1. By fixing the length of the PDMAEMA
block, the amine to phosphate ratio between the polymer
block and origami remains the same, while the effect of PEG
blocks and different polymer structures on binding can be
studied.
Polymer binding to DNA origami
A DNA origami nanostructure, dubbed 60-helix bundle (60HB),
was prepared and characterized as reported previously.48
Agarose gel electrophoresis and transmission electron
microscopy (TEM) were used to verify the quality of the folding
(Fig. 3). Fig. 3A shows how the mobility of a pure scaffold
strand (left lane) in gel differs from that of completely folded
origami (right lane). The additional band on the right lane
corresponds to the excess staple strands present in the folding
mixture. The agarose gel in Fig. 3A was run prior to spin filter-
ing which was used to remove the excess staple strands.
TEM micrographs were taken to confirm the proper assem-
bly of the origamis. Fig. 3B shows the structural details of the
DNA origami and highlights the precise folding.
The binding of the polymers on the origami surface was
studied with gel electrophoresis, ethidium bromide assay and
TEM. TEM micrographs reveal that by adding the polymer, the
structural details of the origami surface disappear, and the
objects become rounded (smooth edges) (Fig. 4A). The TEM,
however, did not reveal any significant differences between the
structures of separate origami–polymer complexes.
The gel electrophoresis, in contrast, displays slight differ-
ences in the complex formation between separate polymers.
The agarose gel clearly shows that polymers bind on the
origami surface and alter the charge, size and shape thus
changing the mobility of the origamis in the gel (Fig. 4B).
The molar amounts of the polymer required to immobilize
the 60HB origami in the gel varies between the ABA, AB and
homopolymer. The ABA-type copolymer changes the 60HB
origami mobility with lower polymer concentration than the
AB and homopolymer (HP). A molar ratio of npolymer/norigami =
400 for ABA was enough to immobilize the complexes, whereas
the ratio of npolymer/norigami = 1200 was needed for the other
two polymers to reach a similar effect. In order to take the cat-
ionic block length and number into account, the values can
also be presented as the ratio of the total number of polymer
amines and the total number of origami phosphates (nN+/nP−).
ABA has two cationic blocks, and indeed by looking at the
nN+/nP− ratio (Fig. 4B, lower values), the results show that all of the
polymers prevent the electrophoretic mobility of DNA origamis
Table 1 After synthesis, all the products were carefully characterized as follows
Polymer DP (PDMAEMA) DP (PEG) Mn (g mol
−1) Mw/Mn
c
PDMAEMA (HP) 35b — 5700b 1.31
PEG macroinitiator — 115b 5200b 1.04
PEG-PDMAEMA (AB) 38a 120a 11 300a 1.12
PEG difunctional macroinitiator — 95b 4600b 1.03
PDMAEMA-PEG-PDMAEMA (ABA) ∼39/blocka 95 18 800c 1.29
a Calculated from 1H NMR. bDetermined with MALDI-ToF. cMeasured with SEC. DP = degree of polymerization.
Fig. 3 (A) Agarose gel was run to verify the quality of the folding. Left
lane: scaffold strand M13mp18 as a reference. Right lane: DNA origami
and excess staple strands. (B) TEM image of the 60HB structures.
Fig. 2 Three polymers were prepared utilizing the Atom Transfer
Radical Polymerization (ATRP) technique. Homopolymer PDMAEMA was
prepared using a commercial ATRP initiator, ethyl α-bromoisobutyrate.
The copolymers were synthesized using the PEG-macroinitiators. Two
separate copolymer structures were synthesized, PDMAEMA-PEG (AB-
type) and PDMAEMA-PEG-PDMAEMA (ABA-type).
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with similar nN+/nP− ratios. Therefore, the PDMAEMA-block
content in all of the immobilized samples is roughly equal and
indicates that increasing the number of cationic blocks does
not improve the relative binding affinity.
A similar type of binding behavior can also be observed by
using the ethidium bromide (EthBr) displacement assay (see
the ESI†). The ABA-type copolymer is able to decrease the
EthBr fluorescence slightly more efficiently than the homo-
polymer (HP) or the AB-type copolymer, whereas the difference
between the latter two is less prominent.
Cell viability with the polymers and polymer–origami complexes
The possible toxicity of the prepared polymer–60HB complexes
and bare polymers was studied using a colorimetric 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
dye assay. We used adenocarcinomic human alveolar basal epi-
thelial cells (A549) and incubated them (1 h or 9 h) with poly-
mers and polymer–origami complexes at physiologically
relevant concentrations (DNA origami concentration 0.5 nM,
polymers were added 10×, 100×, 1000× and 10 000× excess;
bare polymer concentrations 5 nM, 50 nM, 500 nM and 5 µM).
In addition, we used polyethylenimine (PEI, ∼75 kDa) and PEG
(6 kDa) as positive and negative controls, respectively. The cell
viability can be seen in Fig. 5. During the one-hour incubation
with the polymers and complexes, the cells retained their via-
bility throughout the concentration range, whereas PEI as a
positive control showed high activity. For the nine-hour incu-
bation, PEI showed again the highest activity, and also the
incubation with bare ABA polymers at high concentrations
started to cause cell deaths, mainly due to their large cationic
content. However, ABA–60HB complexes (and all HP and AB
containing samples; both bare polymers and complexes)
showed only insignificant activity.
Tuning enzyme reaction rates with polymer coating
To further study the functionality of the DNA structures coated
with the polymers, we used a tubular DNA origami, dubbed
hexagonal tube (HT), which is reported and characterized in a
previous work.49 A HT origami was loaded with streptavidin-
Lucia enzymes (InvivoGen) through three biotinylated binding
sites on its inner surface (Fig. 6A inset). The excess amount of
added enzyme was removed using the spin-filtering procedure
(see the ESI†). The Lucia enzyme (LUC) provides a highly sensi-
tive and flash-like bioluminescence reaction when combined
with a coelenterazine-based substrate (InvivoGen). With these
structures we were able to systematically study the effect of
different (HP, AB and ABA) polymer coatings on the lumine-
scence decay rates of luciferase-equipped DNA origamis (LUC-
origami).
LUC-origami decay assays (35 nM origami) and control
assays of free enzymes (with and without the added polymers)
with the coelenterazine-based substrate in HEPES/NaOH-
based buffer (pH 6.8) were analyzed using the standard
stretched exponential law,50
IðtÞ ¼ Aexpððt=TÞβÞ; ð1Þ
where I(t ) = luminescence intensity, A = constant, T = time con-
stant of the reaction and β = stretching exponent (0 < β ≤ 1).
The enzyme concentrations in the control assays (without
origamis) were tailored to match the decay kinetics of the “(0×)
LUC-origami” sample, i.e. the luminescence intensity levels,
time constant (∼40–50 s) and the stretching exponent (∼0.85)
Fig. 5 MTT assay of the polymers and polymer–60HB complexes. DNA
origami concentration in all complexes is 0.5 nM (polymer concen-
tration varies between 5 nM–5 µM). A549 human epithelial cells were
incubated with the polymers for 1 h or 9 h before measuring the cell via-
bility. The data consists of the average values measured from two inde-
pendent sample sets and the error bars represent the data range.
Fig. 4 (A) TEM micrographs showing (left to right) native origami
(60HB), PDMAEMA-PEG-PDMAEMA-coated origami (ABA) with npolymer/
norigami = 200, PDMAEMA-coated origami (HP) with npolymer/norigami =
600 and PEG-PDMAEMA-coated origami (AB) with npolymer/norigami =
600. (B) Native 60HB origami (leftmost lane) was run in an agarose gel
along with 60HB–polymer complexes. The amine to phosphate ratio is
denoted as (nN+/nP−).
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were adjusted to be similar. It was noticed, that all the
samples (polymer concentration varied between 0–1000× with
respect to origamis) obeyed stretched exponential behaviour
(fitted β varied between 0.73–0.87). An example of the normal-
ized decay assay (A = 1) and the data fits can be seen in Fig. 6A
(LUC-origami complexed with HP). Time constants (from the
fits) for all the polymer–origami complexes (HP, AB and ABA-
coated) are shown in Fig. 6B–D. The fitting parameters T and β
for all the samples are listed in the ESI.†
LUC-enzymes showed appropriate catalytic activity in all
samples (0–1000× polymer coating) indicating that the added
polymer is not capable of blocking the enzyme activity com-
pletely. Importantly, the characteristic reaction time constant
(T ) was gradually prolonged for LUC-origamis, but not for
the free enzymes when the polymers were incorporated. The
trend is clearly seen in Fig. 6. The increase in the T value
was most pronounced when the thickest coating (1000×
polymer concentration) was used. For 1000× HP, 1000× AB
and 1000× ABA, the prolongation factors of the T value were
2.1, 2.0 and 1.7, respectively. As mentioned above, the reac-
tion time constant remained constant in all the control
samples (free enzyme with polymers), thus indicating
that the enzymes need to be encapsulated into/attached to
origamis in order to achieve the prolongation. A plausible
explanation is that the polymer coating of the origami limits
the accessibility of the enzymes and restricts the diffusion
rate of the substrate. This observation could lead to interest-
ing applications, where the cationic polymer coatings could
be utilized as protective layers for origami containers loaded
with molecular cargos. Besides shielding of the origami, the
tunable coating would also allow control over the kinetics of
its enzymatic payload.
Conclusions
In this article we have verified that the PDMAEMA-based
homo- and block copolymers are readily synthesizable via the
ATRP; appropriate control over molecular weight and poly-
dispersity indices was obtained. Moreover, the synthesis is fast
and can be done under relatively mild conditions. To further
demonstrate the feasibility of the polymers in possible bio-
applications, we have systematically shown that the polymers
can bind efficiently to brick-like and tubular DNA origami
nanostructures through electrostatic interactions. However, it
should be emphasized here that the efficiency of the polymer
binding to two different origamis could not be directly com-
pared with each other. The origamis are fundamentally dis-
tinct in structure; for 60HB, only the outer surface is used for
binding, whereas there are both inner and outer surfaces avail-
able in the tubular origami design. Thus, the polymer size and
charge can play a different role in these cases. For example,
small HPs can bind more efficiently to the inner surface of the
tube and restrict the accessibility of the enzymes, which then
results in the prolongation of the characteristic time constant.
Moreover, the surface of the tubular origamis contains bound
enzymes that may also conjugate with the polymers to some
extent (compared to bare 60HB).
In the case of 60HB, the most efficient binding (in terms
of molar ratios) was achieved with the ABA-type block co-
polymer PDMAEMA-PEG-PDMAEMA. The advantage of the
PEG-containing polymers is that besides the cationic binding
properties, they could simultaneously provide the protective
features (PEG-moiety). Moreover, controllable polymer coat-
ings could find uses in improving the transfection rates of
DNA origami shapes and concurrently enhancing the stability
of origamis in biologically relevant environments, although it
was not directly demonstrated in this work. However, here we
have already shown that these cationic polymers possess a
great potential in possible delivery applications. We have
proven that different polymer coatings could be used in con-
trolling the catalytic activity of tubular enzyme-loaded DNA
origami nanocontainers. Moreover, the polymer–origami
complexes are insignificantly toxic at the biologically relevant
concentration levels used in this work (polymer concen-
tration varied between 5 nM–5 µM in the MTT assay). There-
fore, we believe that the presented features could find
intriguing uses in various drug-delivery approaches in the
near future.
Fig. 6 (A) Luminescence decay assay for the hexagonal tube origami
equipped with streptavidin-Lucia (LUC) enzymes (inset). Homopolymer
(HP) is added 100× and 1000× excess to DNA origami (10× omitted for
clarity), which causes the change in the reaction rate (time constant is
prolonged). Red, blue and green lines are fits to the data (stretched
exponential functions). (B)–(D) Fitted normalized time constants of the
luminescence decay for LUC-origami (blue) and free LUC enzymes
(control assay without origamis, green) complexed with HP, AB and ABA,
respectively. Time constants were determined with 4 different polymer
concentrations (0×, 10×, 100× and 1000× with respect to DNA origami).
For each case, the sample without added polymer has been normalized
to 1. The data consists of the average values measured from two inde-
pendent sample sets and the error bars represent the data range.
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Macroinitiator and (co)polymer syntheses. The macroinitia-
tor and polymer synthesis procedures were adopted from
Zhang et al.51 and Even et al.52 The monofunctional and
difunctional macroinitiators were synthesized by utilizing
esterification reaction between 2-bromoisobutyryl bromide
and poly(ethylene glycol)monomethyl ether (mPEG) or poly-
(ethylene glycol) (PEG), respectively. The polymers were pre-
pared utilizing the ATRP technique. Block copolymers were
prepared using the synthesized macroinitiators and homopoly-
mer by using the commercial ethyl α-bromoisobutyrate ATRP
initiator. All the polymer syntheses were conducted in tetra-
hydrofuran (THF), using the 1,1,4,7,10,10-hexamethyltriethyl-
enetetramine (HMTETA) ligand and copper bromide (CuBr)
catalyst. The reaction time varied between 2.5 and 4 hours and
the reaction temperature was either 25 °C or 40 °C. Full details
are presented in the ESI.†
Preparation of DNA origami nanostructures. DNA origamis
were prepared as reported by Linko et al.48,49 The DNA origami
employed in the binding assay, 60-helix bundle (60HB), is a
cuboid-shaped nano-object with dimensions of approximately
20 nm × 20 nm × 40 nm. The origami used in the lumine-
scence decay assays is a hexagonal tube (HT) with the follow-
ing dimensions: width 27–32 nm, cavity width 14–21 nm and
length 30 nm. The scaffold strand, M13mp18 single-stranded
DNA (New England Biolabs or Tilibit Nanosystems), and the
staple strands (IDT, standard desalting), were mixed with
folding buffer and folded using a 58-hour annealing ramp
(from 65 °C to 40 °C).
Preparation of DNA origami–polymer and DNA origami–
enzyme complexes. DNA origami was mixed with buffer
(HEPES/NaOH, 6.5 mM HEPES, pH 6.8) and polymer solutions
to obtain 1 nM (60HB) and 35 nM (hexagonal tube) origami
solutions with varying polymer/origami ratios. The mixture
was incubated for two hours at room temperature to allow the
formation of the complexes.
For the luminescence assay, the spin-filtered origamis were
incubated at least 6 h with the bioluminescent streptavidin-
Lucia (LUC) luciferase enzymes (InvivoGen). The enzymes were
added to the origamis in excess amounts, and thus the
unbound enzymes were removed by spin-filtering (HEPES/
NaOH buffer, 6.5 mM HEPES, pH 6.8) (see the ESI† for the
efficiency of purification).
For more detailed description of the macroinitiator and
polymer syntheses as well as DNA origami and complex prepa-
ration, see the ESI.†
Characterization
Nuclear magnetic resonance (NMR) spectra were recorded with
a Bruker Avance 400 MHz spectrometer. The chemical shifts
were calibrated using residual CHCl3 peaks. The IR spectra
were recorded with a Nicolet 380 FT-IR spectrometer. Gel per-
meation chromatography was performed with a setup consist-
ing of a Waters 515 HPLC-pump, Waters Styragel-columns and
a Waters 2410 refractive index detector. The SEC measurements
were run in DMF containing 1% of LiBr and calibrated with
poly(methyl methacrylate) standards. The transmission electron
microscope images were obtained with a Tecnai 12 Bio-Twin
and JEM 3200FSC field emission microscope (JEOL, 300 kV) in
bright field mode. The gel electrophoresis tests were run in
0.8% agarose gel with EthBr (80 µl, 0.625 mg ml−1) and MgCl2
(11 mM) using 1× TAE (40 mM tris(hydroxymethyl)amino-
methane (Tris), 1 mM ethylenediamine tetra acetic acid (EDTA)
and acetic acid, pH 8.3) running buffer with 11 mM MgCl2. The
fluorescence spectra were recorded with an Agilent Techno-
logies Cary Eclipse Fluorescence Spectrometer. MALDI-ToF
analyses were carried out with an UltrafleXtreme 2000 Hz
instrument (Bruker Daltonics, Bremen Germany) equipped with
a SmartBeam II laser (355 nm), operated in positive mode. Typi-
cally, mass spectra were acquired by the accumulating spectra
of 10 000 laser shots. FlexAnalysis v3.4 was used to assign mole-
cular isotopic masses for polymers. The luminescence decay
assay was prepared by mixing 50 µl of the ready coelenterazine-
based substrate, Quanti-Luc (InvivoGen), with 10 µl of the ready
sample and measuring the luminescence immediately (10 s
delay due to the measurement setup). A BioTek Cytation 3 Cell
Imaging Multi-Mode Reader was employed in the luminescence
decay assay and in the MTT assay.
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